Form 8-K Pacira BioSciences, Inc. For: Feb 26
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- US stock futures rise after previous session's selloff
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- SpaceX shares fall as second lockup period ends
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
Pacira BioSciences (PCRX) Announces CFO Departure
February 29, 2024 8:15 AM ESTOn February 26, 2024, Pacira BioSciences (NASDAQ: PCRX) and Charles A. Reinhart, III, the Companys Chief Financial Officer, agreed that he will depart the Company, effective September 30, 2024 (the Transition Date). The Company has commenced a search for a successor to Mr. Reinhart.
In connection with his departure and the services Mr. Reinhart will provide during the transition period, the Company and Mr. Reinhart agreed, subject to execution and non-revocation of a customary release of claims against the Company,... More
